Samjin Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1968-04-18
- Employees
- 781
- Market Cap
- -
- Website
- http://www.samjinpharm.co.kr
Clinical Trials
9
Active:0
Completed:9
Trial Phases
3 Phases
Phase 1:3
Phase 2:3
Phase 4:3
Drug Approvals
34
PHILIPPINES:34
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (33.3%)Phase 2
3 (33.3%)Phase 4
3 (33.3%)A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke
Phase 4
Completed
- Conditions
- Stroke, Acute
- Interventions
- Drug: Sodium Chloride 45mg/5ml
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Target Recruit Count
- 446
- Registration Number
- NCT05301712
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: SA001 240mg + Rebamipide 200mg or PlaceboDrug: SA001 480mg or PlaceboDrug: SA001 710mg + Rebamipide 600mg or PlaceboDrug: SA001 1,080mg or PlaceboDrug: SA001 360mg or PlaceboDrug: SA001 720mg or Placebo
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT05303961
Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
Phase 4
Completed
- Conditions
- Chronic Hepatitis b
- Interventions
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Target Recruit Count
- 113
- Registration Number
- NCT05286346
- Locations
- 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
Phase 4
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Target Recruit Count
- 118
- Registration Number
- NCT05282407
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome
Phase 2
Completed
- Conditions
- Primary Sjögren's Syndrome (pSS)
- Interventions
- Drug: SA001 Low doseDrug: SA001 Mid doseDrug: SA001 High doseDrug: Placebo
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT05269810
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found